A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

Conditions:   Ventral Hernia;   Abdominal Hernia Interventions:   Drug: BOTOX Dose A;   Drug: Placebo for BOTOX;   Drug: BOTOX Dose B;   Drug: BOTOX Dose C Sponsor:   AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials